Clonidine Benefits Children with Attention Deficit Disorder and Hyperactivity: Report of a Double-Blind Placebo-Crossover Therapeutic Trial
- 30 September 1985
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Child Psychiatry
- Vol. 24 (5) , 617-629
- https://doi.org/10.1016/s0002-7138(09)60065-0
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: Growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivityLife Sciences, 1984
- Stimulant therapy for attention disordersJAMA, 1982
- ADD: not limited to children?JAMA, 1982
- Overrepresentation of adoptees in children with the attention deficit disorderBehavior Genetics, 1982
- Noradrenaline and selective attention: A review of the model and the evidenceLife Sciences, 1980
- Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) in man: Preliminary reportLife Sciences, 1980
- Growth of Hyperactive Children Treated with MethylphenidateJournal of Learning Disabilities, 1978
- Reward, attention and the dorsal noradrenergic bundleBrain Research, 1978
- Response of Adolescents with Minimal Brain Dysfunction to MethylphenidateJournal of Learning Disabilities, 1977
- CSF monoamine metabolites in children with minimal brain dysfunction: Evidence for alteration of brain dopamineThe Journal of Pediatrics, 1977